Clinical cancer research : an official journal of the American Association for Cancer Research
Systemic immune correlates of long-term survival after Delta-24-RGD based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET).
Chibawanye I Ene, Sanjay Singh, Thiagarajan Venkataraman, Lynette M Phillips, James P Long, Deep Singh, Nam D Tran, Frank Tufaro, P J Anand, Nicholas Navin, Sujit Prabhu, Jeffrey S Weinberg, H Benjamin Larman, Candelaria Gomez-Manzano, Juan Fueyo
Published: 202610.1158/1078-0432.CCR-25-3566
Abstract
PURPOSE: To evaluate the combination of intra-tumoral Delta-24-RGD and subcutaneous interferon gamma (IFN-g) in patients with high grade glioma (HGG), based on the rationale that augmenting the immune response with IFN-g will increase the efficacy of…
Preview only. Read the full abstract at the source